We performed a multivariate analysis with the following variables: ALT, age of the patient, type of underlying condition, severe neutropenia, and days from CVC insertion to infection among the population with an indication of adjunctive ALT therapy based on the IDSA guideline’s recommendations [19]. This evidence concerns the gene GPT and infection.